Literature DB >> 16923535

The role of CR2 in autoimmunity.

Andrea Isaák1, József Prechl, János Gergely, Anna Erdei.   

Abstract

Complement activation is one of the most powerful mechanisms taking place during inflammation and immune responses. Over the last 30 years increasing evidence has proven the role of C3 and receptors for its activation fragments in the initiation and regulation of immune responses. Since complement also has a basic importance in the maintenance of immune homeostasis, abnormalities affecting complement proteins and their receptors may lead to pathological conditions. Autoimmune conditions develop as a result of a range of genetic and environmental factors. Findings obtained from animal models support the notion that malfunctioning of complement receptors, particularly CR2, might be involved in the breakdown of tolerance and excessive antibody production by auto reactive B-cell clones. In addition to B cells, activated, CR2-bearing T cells may also contribute to the pathogenesis of autoimmunity as they can receive activating/survival signals in the inflamed tissue. Results obtained from mouse experiments however, should be extended to the human system with great care, since there are basic differences between the structure and function of human and murine CR1 and CR2.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16923535     DOI: 10.1080/08916930600739001

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  7 in total

Review 1.  Complement regulators and inhibitory proteins.

Authors:  Peter F Zipfel; Christine Skerka
Journal:  Nat Rev Immunol       Date:  2009-09-04       Impact factor: 53.106

Review 2.  Dense deposit disease.

Authors:  Richard J H Smith; Claire L Harris; Matthew C Pickering
Journal:  Mol Immunol       Date:  2011-05-24       Impact factor: 4.407

3.  The Sez6 Family Inhibits Complement by Facilitating Factor I Cleavage of C3b and Accelerating the Decay of C3 Convertases.

Authors:  Wen Q Qiu; Shaopeiwen Luo; Stefanie A Ma; Priyanka Saminathan; Herman Li; Jenny M Gunnersen; Harris A Gelbard; Jennetta W Hammond
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

4.  DHA Supplementation Attenuates Inflammation-Associated Gene Expression in the Mammary Gland of Lactating Mothers Who Deliver Preterm.

Authors:  Joselyn M Adams; Christina J Valentine; Rebekah A Karns; Lynette K Rogers; Masahiko Murase; Grace N Fowler; Laurie A Nommsen-Rivers
Journal:  J Nutr       Date:  2022-06-09       Impact factor: 4.687

Review 5.  The role of the complement system in Multiple Sclerosis: A review.

Authors:  Nil Saez-Calveras; Olaf Stuve
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786

6.  Complement receptor 2 is up regulated in the spinal cord following nerve root injury and modulates the spinal cord response.

Authors:  Rickard P F Lindblom; Alexander Berg; Mikael Ström; Shahin Aeinehband; Cecilia A Dominguez; Faiez Al Nimer; Nada Abdelmagid; Matthias Heinig; Johan Zelano; Karin Harnesk; Norbert Hübner; Bo Nilsson; Kristina Nilsson Ekdahl; Margarita Diez; Staffan Cullheim; Fredrik Piehl
Journal:  J Neuroinflammation       Date:  2015-10-26       Impact factor: 8.322

7.  Cytometric profiling in various clinical forms of multiple sclerosis with respect to CD21+, CD32+, and CD35+ B and T cells.

Authors:  Ali Zandieh; Maryam Izad; Mohammad Fakhri; Hamed Amirifard; Zahra Khazaeipour; Mohammad Hosein Harirchian
Journal:  Transl Neurodegener       Date:  2013-07-02       Impact factor: 8.014

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.